A physician will see 80 patients with acute coronary syndrome before encountering ... outline in color directly on the image the aortic arch, the mediastinum, and the path of the trachea.

The secondary endpoints included mediastinum or sternum infection ... Leshnower B, et al. Aortic Arch Management During Acute and Subacute Type A Aortic Syndromes. Ann Thorac Surg. 2022;114(3):694-701 ...

They included 17,642 propensity score–matched adults (mean age, 63.1 years; 26.1% women) who were discharged after an invasive treatment strategy for acute coronary syndrome and received either ...

Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have ...

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced the publication of the detailed results from its TRAVERS Phase 2 trial with AM-125 (intranasal betahistine) in surgery ...

Background: Thoracoabdominal acute aortic syndrome is associated with high morbidity and ... periaortic hematoma, and/or mediastinal hematoma with thickness >10 mm, or significant left pleural ...

Evidence-based recommendations on aortic remodelling hybrid stent insertion for acute type A aortic dissection. This involves inserting a stent with material sewed on one end into part of the aorta.

The long-term health consequences of COVID-19 have refocused our attention on post-acute infection syndromes (PAIS), starting a discussion on the need for a complete understanding of multisystemic ...

Two children underwent right thoracotomy due to anatomical left dominant aortic arch. At surgery, the mediastinal pleura was divided ... to lift this to the anterior chest wall, thereby widening the ...

Acute PCS can be divided into three subtypes: atraumatic (usually after strenuous physical activity), secondary to direct trauma, and secondary to non-spinal surgery (aortic and gastric bypass ...

Because of rapidly changing guidelines in response to multiple clinical trials of new therapies, the management of antithrombotic agents for patients after an acute coronary syndrome is becoming ...